¥1,138.00 ($7.22)

-11.00 (-0.96%)

Weekly Expected Move ±2.7%

¥1086 ¥1117 ¥1149 ¥1181 ¥1212

JPX · Healthcare · Medical - Specialties · Tech Score Buy · Power 65 · ¥9.4B mcap · 3M float · 0.304% daily turnover

Analysis Technicals Weather Peers

Revenue

$13.6B +4.5% ▲

5Y CAGR: +4.7%

Gross Profit

$6.0B +5.1% ▲

5Y CAGR: +3.4%

Operating Income

$1.0B +45.1% ▲

5Y CAGR: +0.4%

Net Income

$714M -15.1% ▼

5Y CAGR: +1.6%

EPS (Diluted)

$80.75 -15.3% ▼

5Y CAGR: +2.6%

EBITDA

$1.6B -9.1% ▼

5Y CAGR: +2.4%

View Full Income Statement

Line Item	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	$11.7B	$12.3B	$12.6B	$13.0B	$13.6B
YoY Growth	+8.0%	+5.4%	+2.1%	+3.5%	+4.5%
Cost of Revenue	$6.4B	$6.9B	$7.1B	$7.3B	$7.6B
Gross Profit	$5.3B	$5.4B	$5.5B	$5.7B	$6.0B
Gross Margin	45.0%	43.6%	43.5%	43.8%	44.0%
R&D Expenses	$786M	$882M	$850M	$835M	$0
SG&A Expenses	$3.6B	$3.8B	$3.8B	$5.0B	$5.0B
Operating Expenses	$4.4B	$4.6B	$4.7B	$5.0B	$5.0B
Operating Income	$867M	$738M	$803M	$692M	$1.0B
Operating Margin	7.4%	6.0%	6.4%	5.3%	7.4%
Interest Expense	$6M	$7M	$11M	$11M	$8M
Income Before Tax	$966M	$863M	$904M	$1.1B	$1.1B
Tax Expense	$305M	$381M	$750M	$246M	$347M
Net Income	$660M	$482M	$154M	$841M	$714M
Net Margin	5.6%	3.9%	1.2%	6.5%	5.2%
EPS (Diluted)	$72.61	$53.00	$16.92	$95.31	$80.75
EBITDA	$1.4B	$1.5B	$1.5B	$1.7B	$1.6B
Shares Outstanding	9M	9M	9M	9M	9M

Line Item	FY2024 Q3	FY2024 Q4	FY2025 Q1	FY2025 Q2	FY2025 Q3	FY2025 Q4	FY2026 Q1	FY2026 Q2
Revenue	$3.2B	$3.5B	$3.2B	$3.3B	$3.5B	$3.6B	$3.4B	$3.6B
Cost of Revenue	$1.7B	$2.0B	$1.8B	$1.8B	$1.9B	$2.2B	$2.0B	$2.1B
Gross Profit	$1.5B	$1.5B	$1.4B	$1.5B	$1.6B	$1.4B	$1.4B	$1.4B
Gross Margin	46.4%	41.9%	44.0%	46.3%	46.4%	39.6%	41.1%	40.2%
R&D Expenses	-$453M	$835M	$0	$0	$0	$0	$0	$0
SG&A Expenses	$1.3B	$1.3B	$1.2B	$1.2B	$1.3B	$1.3B	$1.2B	$1.2B
Operating Expenses	$1.3B	$1.3B	$1.2B	$1.2B	$1.3B	$1.3B	$1.2B	$1.2B
Operating Income	$230M	$171M	$222M	$326M	$366M	$91M	$141M	$196M
Operating Margin	7.2%	4.9%	6.9%	9.8%	10.5%	2.6%	4.2%	5.5%
Interest Expense	$3M	$2M	$3M	$3M	$761K	$715K	$635K	$552K
Income Before Tax	$168M	$181M	$243M	$314M	$364M	$139M	$171M	$229M
Tax Expense	-$26M	$85M	$34M	$111M	$110M	$92M	$17M	$122M
Net Income	$194M	$96M	$209M	$204M	$254M	$47M	$153M	$107M
Net Margin	6.0%	2.7%	6.5%	6.1%	7.3%	1.3%	4.6%	3.0%
EPS (Diluted)	$22.50	$11.15	$24.38	$23.88	$30.11	$4.18	$16.58	$11.88
EBITDA	$318M	$331M	$391M	$450M	$506M	$236M	$293M	$352M
Shares Outstanding	9M	9M	9M	9M	8M	11M	9M	9M

5187.T JPX